September 14, 2023 ∙ jessica-sacher
Phage therapy
Clinical Trial
Biotech news
Instill Science
A place to discuss science, share work, and find mentors and collaborators
Instill Science / post-9sONLfn1
Loading ...
No comments yet. Be the first to comment!
Intralytix has announced the launch of a Phase 1/2a clinical trial of its VRELysin™ phage preparation to assess safety and efficacy in healthy and VRE-colonized subjects at UPMC in Pittsburgh, Pennsylvania.